
Materials · Industrial Gases
$519.59
+0.99%
Vol: 244K
Monday, June 15, 2026
No material news in the last 48 hours.
No material news in the last 48 hours.
Linde plc issued €600M floating rate notes due 2028, €500M of 3.200% notes due 2030, and €500M of 3.800% notes due 2036 under its European debt program, netting ~€1,595M. Board declared a $1.60 quarterly dividend. Linde announced a new industrial gas facility in Garysburg, NC, producing liquid oxygen, nitrogen and argon, expected to start operations by late 2028. The company backed FY26 capex view of $5B-$5.5B. Q1 2026 adjusted EPS of $4.33 (up 10%) beat by $0.06 with revenue of $8.8B (+8% YoY).
On May 13, 2026, Linde issued 600 million euros of floating rate notes due 2028, 500 million euros of 3.200% notes due 2030, and 500 million euros of 3.800% notes due 2036 under its European debt issuance program, with key subsidiaries as guarantors. The bond sale follows a strong Q1 2026: Linde reported sales of $8.8 billion (up 8% YoY), net income of $1,857 million, and adjusted EPS of $4.33 (beating $4.27 consensus). Full-year 2026 adjusted EPS guidance is $17.60-$17.90 (up 7-9%), with Q2 guidance of $4.40-$4.50. The company raised its annual dividend by 7%, marking its 33rd consecutive year of dividend growth, and repurchased $800 million of stock in Q1. Analysts raised price targets: Citi to $585, BMO to $560, RBC to $570. Risk: weaker volume growth and FX drag on global industrial demand.
No material news in the last 48 hours.
On May 13, 2026, Linde plc issued 1.6 billion euros in euro notes under its debt program, with notes guaranteed by key subsidiaries to enhance liquidity and European capital market access. This follows a strong Q1 with sales up 8% to $8.8B and adjusted EPS up 10% to $4.33, prompting an upward revision in full-year 2026 EPS guidance to $17.60-$17.90. Multiple analysts including Citi, BMO, and RBC raised price targets following the earnings beat. The industrial gas leader's project backlog rose to 4.5 billion euros, supported by blue hydrogen contracts and electronics demand. Risks include geopolitical and supply chain headwinds.
On May 13, 2026, Linde issued EUR1.6B in euro notes (EUR600M FRN due 2028, EUR500M 3.200% due 2030, EUR500M 3.800% due 2036) under its European debt program to enhance liquidity. Q1 2026 sales rose 8% to $8.8B with adjusted EPS up 10% to $4.33, beating the $4.27 consensus on 10% electronics end-market growth. The company raised its annual dividend by 7% (33 consecutive years of growth), repurchased $800M of stock and reinvested ~$1.5B. Q2 adjusted EPS guidance is $4.40-$4.50 (+8-10%) and FY 2026 guidance is $17.60-$17.90 (+7-9%). Citi raised its PT to $585 from $580 (Buy). Average analyst rating is Strong Buy. Bondholder leverage from new euro issuance is the only modest risk flag.
On May 13, 2026, Linde plc issued €1.6 billion of euro notes under its European debt issuance program, comprising €600M floating-rate notes due 2028, €500M of 3.200% notes due 2030, and €500M of 3.800% notes due 2036, guaranteed by key subsidiaries. The issuance enhances liquidity and access to European capital markets. The financing follows strong Q1 2026 results posted May 1 (adjusted EPS +10% YoY to $4.33, revenue +8% to $8.8B) and a 7% dividend increase marking 33 consecutive years of growth. Linde reaffirmed Q2 adjusted EPS guidance of $4.40-$4.50 and raised full-year 2026 guidance. Risk: rising euro borrowing costs and higher interest expense could weigh on margins; the issuance signals continued capital intensity even as the project backlog sits at €4.5B.
Linde reported strong Q1 2026 results on May 1 with sales up 8% to $8.8 billion led by 10% growth in electronics. Adjusted EPS climbed 10% to $4.33, with operating profit reaching $2.6 billion (30% margin, +50bp sequentially). The annual dividend was raised 7%, marking 33 consecutive years of increases. Linde repurchased $800 million of stock and reinvested $1.5 billion during the quarter. Full-year 2026 EPS guidance was reaffirmed at $17.60-$17.90, representing 7-9% growth including a 1% currency benefit. Shares rose 1.4% on the report.
Linde reported Q1 2026 adjusted EPS of $4.33, up 10% YoY and beating FactSet consensus by $0.06, on sales of $8.8B up 8% YoY (3% underlying). Americas sales rose 10% to $4.025B, driven by 4% higher pricing and 2% higher volumes in electronics, manufacturing, and metals/mining. The company raised its annual dividend 7%, marking 33 consecutive years of growth, and repurchased $800M of stock. Q2 2026 adjusted EPS guidance of $4.40-$4.50 implies 8-10% YoY growth; full-year guidance is $17.60-$17.90, with the midpoint slightly below some consensus estimates. Citi raised its target to $585 (Buy) and BMO to $560 (Outperform). Analyst consensus is Strong Buy.
Linde reported Q1 2026 with sales up 8% to $8.8B and adjusted EPS up 10% to $4.33, maintaining ~30% operating margins. The company returned $1.5B to shareholders in the quarter, continuing 33 consecutive years of dividend growth. Underlying volume growth was only 1%, with weakness in EMEA. Shares closed down $8.02 (-1.60%) on May 7. Analysts are mixed with bullish targets from BMO and RBC but caution from those calling the stock fully valued at ~28x forward earnings.
Linde reported Q1 2026 EPS of $4.33 beating consensus by $0.06, with $8.78B revenue exceeding $8.60B expectations. The company raised FY2026 guidance reflecting business resilience. Adjusted EPS grew 10% YoY and sales grew 8%, led by 10% growth in electronics segment from AI demand. Linde increased quarterly dividend 7% and declared $1.60/share payable June 18, 2026. BMO Capital raised price target to $560 from $545 with Outperform rating; Citi raised target to $585 from $580 with Buy rating.
Linde reported Q1 2026 sales of $8.78B, beating $8.60B consensus, with adjusted EPS of $4.33 vs. $4.27 estimate. Company set FY2026 EPS guidance at 17.60-17.90 and Q2 guidance at 4.40-4.50. Quarterly dividend of $1.60 will be paid June 18, 2026 (1.3% yield; $6.40 annualized). Deutsche Bank maintained Buy with $575 target; JPMorgan raised to $530 from $525. LIN included in World's Most Ethical Companies list for 6th consecutive year. 8 analysts rate as Strong Buy with 12-month target of $546.63 (+9.24% upside).
Linde reported Q1 2026 EPS of $4.33 (+10% YoY), beating consensus of $4.27, with revenue of $8.78B (+8.2% YoY) topping estimates of $8.60B. Americas sales grew 10% and Asia Pacific +11%. Stock rose 3.33% on May 1 following earnings. Board declared 7% dividend increase to $1.60/share, payable June 18. FY 2026 guidance set at $17.60-17.90 EPS (midpoint slightly below some estimates). Q2 2026 guidance $4.40-4.50 EPS. Analyst consensus is Strong Buy with 12-month target of $543.13 (+9.72%).
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LINLINDE | $519.59 | +0.99% | +0.7% | 26.1x | 0.74 | $237.9B |
| APDAIR | $278.44 | -4.05% | -1.1% | 20.4x | 0.78 | $64.6B |
| NEMNEWMONT | $106.40 | -1.78% | -1.4% | 9.6x | 0.45 | $115.6B |
| FCXFREEPORT | $71.30 | +14.43% | +3.0% | 16.8x | 1.32 | $89.6B |
| SHWSHERWIN | $323.89 | +4.70% | +2.2% | 23.3x | 1.16 | $76.3B |
| ECLECOLAB | $270.53 | +8.13% | +0.4% | 26.1x | 0.93 | $70.4B |
Price above both MAs — bullish structure.